The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Statement

당뇨병신장질환에서 GLP-1수용체작용제의 역할: 최근 연구 결과: 김진화; J Korean Diabetes. 2025;26(1):5-9. Published online March 30, 2025; DOI: https://doi.org/10.4093/jkd.2025.26.1.5

Focused Issues

비만당뇨병의 관리 전략: 김미숙, 이승환; J Korean Diabetes. 2024;25(3):165-171. Published online September 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.3.165

GLP-1수용체작용제: 정승민; J Korean Diabetes. 2024;25(2):69-75. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.69

Information Desks

최신 당뇨병 치료제의 특징: 윤누리; J Korean Diabetes. 2023;24(3):148-153. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.148

Focused Issues

당뇨병 주사제: Glucagon-Like Peptide-1 수용체작용제: Inkuk Lee, Eun Seok Kang; J Korean Diabetes. 2019;20(3):149-156. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.149
Cited By 2

Opinion

식사 중 탄수화물은 언제 먹어야 하나: Jae Hyun Bae, Young Min Cho; J Korean Diabetes. 2018;19(4):193-199. Published online January 8, 2019; DOI: https://doi.org/10.4093/jkd.2018.19.4.193
Cited By 1

2018년 미국당뇨병학회 진료지침 속의 작지만 큰 변화: Jeong Hyun Park; J Korean Diabetes. 2018;19(2):71-75. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.71
Cited By 1

Focused Issues

제2형 당뇨병 약제치료 지침 2017 개정안: Glucagon-Like Peptide-1 수용체작용제: Hyun Jin Kim; J Korean Diabetes. 2018;19(1):35-40. Published online April 13, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.1.35
Cited By 1

Volume 26, No. 3

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

4,170	Community-Based Intervention for Elderly Patients with Diabetes Mellitus: Assessing the Effectiveness of a YouTube Self-Education Program during the Global COVID-19 Pandemic
6,060	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
5,005	2023 Clinical Practice Guidelines for Diabetes
3,750	Assessment of Insulin Secretion and Insulin Resistance
1,014	Initial Evaluation of Patients with Diabetes Mellitus according to Clinical Guidelines

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2025 by Korean Diabetes Association. All rights reserved.